A drug with the SMILES CCCc1nc2nc(C)c(NS(=O)(=O)c3ccc([N+](=O)[O-])cc3)c(=O)n2[nH]1 has a human ether-à-go-go related gene (hERG) inhibition at 10uM of 13.856%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
CCCc1nc2nc(C)c(NS(=O)(=O)c3ccc([N+](=O)[O-])cc3)c(=O)n2[nH]1
CCCc1nc2nc(C)c(NS(=O)(=O)c3ccc([N+](=O)[O-])cc3)c(=O)n2[nH]1
N-(5-methyl-7-oxo-2-propyl-1H-[1,2,4]triazolo[1,5-a]pyrimidin-6-yl)-4-nitrobenzenesulfonamide